Cover Image

A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME

Background: Siglec-15 (S15) is a type-I transmembrane protein and is considered a new candidate of immune checkpoint inhibitor for cancer immunotherapy. Methods: In the present study, we first constructed and characterized a chimeric S15-specific monoclonal antibody (S15-4E6A). Then, the antitumor e...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuejun Xiao (Author), Yan Peng (Author), Zheyue Wang (Author), Louqian Zhang (Author), Tingting Yang (Author), Yangyang Sun (Author), Yufeng Chen (Author), Wenqing Zhang (Author), Xinxia Chang (Author), Wen Huang (Author), Shuning Tian (Author), Zhenqing Feng (Author), Nabi Xinhua (Author), Qi Tang (Author), Yuan Mao (Author)
Format: Book
Published: Elsevier, 2022-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items